CXCR3 (CD183) (Carboxyfluorescein) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-CXCR3 (CD183) (Carboxyfluorescein) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCXCR3 (CD183) (Carboxyfluorescein)
Clone[2Ar1]
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG1
FormatProtein G purified
Size1 mL
Concentration0.05 mg/ml
ApplicationsFlow Cytometry (FC/FACS)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRecognizes human CXCR3. Reacts specifically with CXCR3 transfectants and not the parental cell line using FACS analysis. Does not crossreact with CXCR1, CXCR2 and CXCR4 transfectants. CXCR3 is a cell surface chemokine receptor that belongs to the family of G protein linked, seven transmembrane domain containing receptors. With the cloning of this molecule, it was identified as the specific receptor for two CXC chemokines: gamma interferon induced protein and monokine induced by interferon gamma (1). The CXCR3 receptors appear to have affinity for CXC chemokines that do not contain the conserved ELR motif at their amino terminus and as a result IL-8 and platelet factor 4 (PF4) do not bind to this receptor (2). CXCR3 shares approximately 40%
ImmunogenImmunogen: NSO mouse myeloma cell line transfected with human CXCR3 (aa1-368). (P49682)
Other Names[-CXCR3 (CD183) (Carboxyfluorescein)], [CXCR3; CXCR3; GPR9; MigR; CD182; CD183; Mig-R; CKR-L2; CMKAR3; IP10-R; GPR9]
Gene, Accession #Gene ID: 2833, NCBI: NP_001136269.1, UniProt: P49682
Catalog #MBS601531
Price$590
Order / More InfoCXCR3 (CD183) (Carboxyfluorescein) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.